Etodolaco [Inn-Spanish]

Etodolaco [Inn-Spanish] Brand names, Etodolaco [Inn-Spanish] Analogs

Etodolaco [Inn-Spanish] Brand Names Mixture

No information avaliable

Etodolaco [Inn-Spanish] Chemical_Formula

C₁₇H₂₁NO₃

Etodolaco [Inn-Spanish] RX_link

http://www.rxlist.com/cgi/generic/etodolac.htm

Etodolaco [Inn-Spanish] fda sheet

Etodolaco_[Inn-Spanish] FDA

Etodolaco [Inn-Spanish] msds (material safety sheet)

Etodolaco [Inn-Spanish] Synthesis Reference

C. A. Demerson et al., U.S. Pat. 3,939,178 (1976)

Etodolaco [Inn-Spanish] Molecular Weight

287.354 g/mol

Etodolaco [Inn-Spanish] Melting Point

145-148 ^oC

Etodolaco [Inn-Spanish] H₂O Solubility

16 mg/L

Etodolaco [Inn-Spanish] State

Solid

Etodolaco [Inn-Spanish] LogP

No information avaliable

Etodolaco [Inn-Spanish] Dosage Forms

Tablet; Tablet (extended-release)

Etodolaco [Inn-Spanish] Indication

For acute and long-term use in the management of signs and symptoms of osteoarthritis and rheumatoid arthritis, as well as for the management of pain.

Etodolaco [Inn-Spanish] Pharmacology

Etodolac, an antiinflammatory agent with analgesic and antipyretic properties, is used to treat osteoarthritis and control acute pain.

Etodolaco [Inn-Spanish] Absorption

Based on mass balance studies, the systemic availability of etodolac from either the tablet or capsule formulation, is at least 80%.

Etodolaco [Inn-Spanish] side effects and Toxicity

Symptoms of overdose include lethargy, drowsiness, nausea, vomiting, and epigastric pain.

Etodolaco [Inn-Spanish] Patient Information

Lodine, like other drugs of its class, can cause discomfort and, rarely, more serious side effects, such as gastrointestinal bleeding, which may result in hospitalization and even fatal outcomes. Although serious GI tract ulcerations and bleeding can occur without warning symptoms, patients should be alert for the signs and symptoms of ulcerations and bleeding, and should ask for medical advice when observing any indicative sign or symptom. Patients should be informed of the importance of this follow-up Effects Risk of GI Ulceration, Bleeding, and Perforation).

Patients on Lodine (etodolac capsules and tablets) should report to their physicians signs or symptoms of gastrointestinal ulceration or bleeding, blurred vision or other eye symptoms, skin rash, weight gain, or edema.

Patients should also be instructed to seek medical emergency help in case of an occurrence of anaphylactoid reactions.

Etodolaco [Inn-Spanish] Organisms Affected

Humans and other mammals